Image

Comparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer

Comparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer

Recruiting
18-75 years
All
Phase N/A

Powered by AI

Overview

This study includes patients diagnosed with proximal gastric cancer (Siewert type II/III, cT1-3N0-1M0) across six tertiary hospitals, who underwent either double-tract reconstruction (DTR) or tubular gastric anastomosis (TGA). Participants were divided into two groups based on the surgical procedure. We conducted a comparative analysis of postoperative outcomes by evaluating electronic medical records, postoperative gastroscopy, 24-hour esophageal pH monitoring, and relevant rating scales.

Eligibility

Inclusion Criteria:

  • Pathologically confirmed gastric adenocarcinoma by biopsy
  • Carcinoma of the upper gastric body or Siewert type II/III adenocarcinoma of the esophagogastric junction (AEG), with a clinical stage of cT1-3N0-1M0
  • Age 18-75 years, with a performance status (PS) score of 0-2
  • Candidates for planned surgical resection, eligible for either double-tract reconstruction or tubular gastric anastomosis based on preoperative assessment
  • No severe dysfunction of vital organs (liver, kidney, heart, lung, or brain), and no severe infection or uncontrolled chronic diseases

Exclusion Criteria:

  • Presence of other malignant tumors or severe chronic diseases (e.g., severe diabetes mellitus, chronic kidney disease, decompensated cirrhosis, etc.)
  • Preoperative endoscopic diagnosis of Barrett's esophagus
  • Severe preoperative malnutrition (albumin \<30 g/L, prealbumin \<150 mg/L)
  • History of prior upper abdominal surgery, gastrointestinal malformation, or psychiatric disorders
  • Preoperative diagnosis of obstructive motor disorders of the cardia (including achalasia spectrum disorders)
  • Inability to cooperate with or complete the required postoperative examinations

Study details
    Gastric Cancer (GC)
    Double-tract Reconstruction
    Tubular Gastric Anastomosis

NCT07635836

Qilu Hospital of Shandong University

27 June 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.